Catalyst Pharmanceuticals, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment
No. 1
to
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Catalyst Pharmaceutical Partners, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
Delaware
|
|
76-0837053 |
|
|
|
(State of Incorporation or Organization)
|
|
(I.R.S. Employee Identification No.) |
|
|
|
220 Miracle Mile, Suite 234 |
|
|
Coral Gables, Florida
|
|
33134 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the
Exchange Act and is effective pursuant to General Instruction A.(c)., check the following box x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the
Exchange Act and is effective pursuant to General Instruction A.(d)., check the following box. o
Securities Act registration statement file number to which this form relates: 333-136039
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class to be registered
|
|
Name of each exchange on which
each class is to be registered |
|
|
|
Common Stock, par value $0.001 per share
|
|
Nasdaq Stock Market, LLC |
Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrants Securities to be Registered
A description of the Common Stock to be registered hereunder is contained in the section
entitled Description of Our Capital Stock in the prospectus included in the Registrants
Registration Statement on Form S-1, File No. 333-136039, initially filed with the Securities and
Exchange Commission on July 25, 2006, as amended from time to time (the Registration Statement).
Such description and any amendments or reports filed for the purpose of updating such description
is incorporated herein by reference.
Item 2. Exhibits
|
|
|
Exhibit Number |
|
Description of Document |
|
|
|
3.1*
|
|
Certificate of Incorporation |
3.2*
|
|
Amendment to Certificate of Incorporation |
3.3*
|
|
By-laws |
4.1*
|
|
Specimen stock certificate for common stock |
|
|
|
* |
|
Filed as a like-numbered exhibit to the Registration Statement, which is incorporated herein by
reference. |
2
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the
registrant has duly caused this Amendment No. 1 to Form 8-A to be signed on its behalf
by the undersigned, thereto duly authorized.
|
|
|
|
|
|
CATALYST PHARMACEUTICAL PARTNERS, INC.
|
|
|
By: |
/s/ Patrick J. McEnany
|
|
|
|
Patrick J. McEnany |
|
Dated: October 18, 2006 |
|
Chief Executive Officer |
|
|
3